25.37USD+0.12%Mkt Cap: —P/E: 25.34Last update: 2026-05-26
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty paymen…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value377.87M USD
Revenue (TTM)48.55M USD
Gross Profit48.09M USD
Net Income (TTM)31.71M USD
Revenue/Share4.025 USD
Last Price25.37 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)25.34
P/E (Forward)—
PEG—
EV/EBITDA45.55
EV/Revenue7.78
P/S—
P/B3.60
EPS (TTM)1.00
EPS (Forward)—
52W Range
25.145% of range30.00
52W High30.00 USD
52W Low25.14 USD
Profitability
Gross Margin99.04%
Oper. Margin-3.90%
EBITDA Margin17.08%
Profit Margin271.97%
ROE37.78%
ROA11.63%
Growth
Revenue Growth-22.60%
Earnings Growth207.90%
Cash Flow & Leverage
Operating CF2.87M USD
CapEx (TTM)20.73M USD
FCF Margin-26.92%
FCF Yield—
Net Debt38.64M USD
Net Debt/EBITDA4.66
Balance Sheet
Debt/Equity1.57
Current Ratio3.59
Quick Ratio3.31
Book Value/Sh7.074 USD
Cash/Share6.865 USD
Dividends
Fwd Div Rate2.160 USD
Trail. Div Rate0.0000 USD
Div. Yield8.47%
5Y Avg Yield8.14%
Payout Ratio—
Ex-Div DateApr 2, 2026
Pay DateApr 15, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float914.87K
Insiders0.00%
Institutions1.02%
Short Interest
Short Ratio0.0d
Shares Short1.57K
Short (prev mo.)625
Technical
SMA 5025.78 (-1.6%)
SMA 20026.17 (-3.1%)
Beta0.90
S&P 52W Chg28.31%
Avg Vol (30d)3.31K
Avg Vol (10d)1.29K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—